Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 51 publications
Cholangiocyte RUNX1 Orchestrates Fibrogenic and Inflammatory Signaling to Drive Biliary Fibrosis.
Journal: bioRxiv : the preprint server for biology
Published: June 04, 2026
Cholangiocyte biology in primary sclerosing cholangitis and other cholangiopathies: pathogenesis, clinical insights, and experimental tools.
Journal: Physiological reviews
Published: April 13, 2026
Microencapsulation of pluripotent stem cell-derived pancreatic and liver cells: biological needs and technological solutions.
Journal: Biomaterials science
Published: June 17, 2025
Comparative analysis of small molecule and growth factor-derived human induced pluripotent stem cell-derived hepatocyte-like cells.
Journal: Frontiers in cell and developmental biology
Published: March 15, 2025
LncRNAs, RNA Therapeutics, and Emerging Technologies in Liver Pathobiology.
Journal: Seminars in liver disease
Published: November 27, 2024
Aramchol attenuates fibrosis in mouse models of biliary fibrosis and blocks the TGFβ-induced fibroinflammatory mediators in cholangiocytes.
Journal: bioRxiv : the preprint server for biology
Published: November 22, 2024
Aramchol attenuates fibrosis in mouse models of biliary fibrosis and blocks the TGFβ-induced fibroinflammatory mediators in cholangiocytes.
Journal: Hepatology communications
Published: November 13, 2024
Glycolysis in hepatic stellate cells coordinates fibrogenic extracellular vesicle release spatially to amplify liver fibrosis.
Journal: Science advances
Published: June 28, 2024
Central role for cholangiocyte pathobiology in cholestatic liver diseases.
Journal: Hepatology (Baltimore, Md.)
Published: June 24, 2024
First Application of a Mixed Porcine-Human Repopulated Bioengineered Liver in a Preclinical Model of Post-Resection Liver Failure.
Journal: Biomedicines
Published: March 29, 2024
Last Updated: 09/26/2026